{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T13:20:46Z","timestamp":1778160046003,"version":"3.51.4"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["111-2314-B-002-266"],"award-info":[{"award-number":["111-2314-B-002-266"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["112-2314-B-002-141"],"award-info":[{"award-number":["112-2314-B-002-141"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["112-2326-B-002-005"],"award-info":[{"award-number":["112-2326-B-002-005"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["113-2326-B-002-013"],"award-info":[{"award-number":["113-2326-B-002-013"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Fas ligand (FasL)-mediated apoptosis constrains immune responses by eliminating activated lymphocytes, yet how FasL is delivered to the plasma membrane in myeloid cells remains unclear. We identify the RING E3 ligase ZNRF1 as a macrophage-intrinsic checkpoint that licenses terminal trafficking and surface exposure of FasL. Myeloid-specific\n                    <jats:italic>Znrf1<\/jats:italic>\n                    deletion caused age-dependent spontaneous splenomegaly and, upon allosensitization, elevated CD4\n                    <jats:sup>+<\/jats:sup>\n                    \/CD8\n                    <jats:sup>+<\/jats:sup>\n                    T-cell ratios, enlarged germinal centers with heightened IL-21\/Tfh activity, and augmented alloantibody production. In macrophages, ZNRF1 deficiency disrupted the link between total and surface FasL. Although cellular FasL levels increased upon stimulation, there was no corresponding elevation in surface FasL, indicating a defect in terminal trafficking or docking. Confocal imaging showed preserved peripheral polarization of LAMP1\u207a lysosome-related organelles while FasL cargo did not co-accumulate at the cortex, indicating a late docking\/fusion defect. Biochemically, ZNRF1 deficiency weakened the Munc18-2 (\n                    <jats:italic>Stxbp2<\/jats:italic>\n                    )\u2013Syntaxin-3 (S\n                    <jats:italic>tx3<\/jats:italic>\n                    ) interaction;\n                    <jats:italic>Stxbp2<\/jats:italic>\n                    knockdown reduced surface FasL, and reconstitution with wild-type ZNRF1\u2014but not the catalytically inactive C184A mutant\u2014restored surface FasL despite similar complex assembly, establishing a requirement for ZNRF1 E3 activity. Functionally,\n                    <jats:italic>Znrf1<\/jats:italic>\n                    -deficient macrophages displayed impaired FasL-dependent killing of activated CD4\u207a T cells and Fas-sensitive targets, not rescued by stronger LPS priming. These findings define a ZNRF1\u2013Munc18-2\u2013Stx3 axis that couples lysosome-related organelle polarization to fusion, ensuring timely FasL availability at the macrophage surface and suggesting a tractable node to modulate immune hyperactivation.\n                  <\/jats:p>","DOI":"10.1038\/s41419-026-08566-8","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T23:35:48Z","timestamp":1774654548000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["ZNRF1 deficiency disrupts Fas ligand trafficking and immune balance"],"prefix":"10.1038","volume":"17","author":[{"given":"Ting-Yu","family":"Lai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8829-5338","authenticated-orcid":false,"given":"Yung-Chi","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"You-Sheng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching-Yi","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pu","family":"Ou-Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1282-976X","authenticated-orcid":false,"given":"Chien-Chia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng-Kun","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7206-5231","authenticated-orcid":false,"given":"Li-Chung","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5034-3544","authenticated-orcid":false,"given":"Chih-Yuan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,28]]},"reference":[{"key":"8566_CR1","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1242\/jcs.114.13.2405","volume":"114","author":"EJ Blott","year":"2001","unstructured":"Blott EJ, Bossi G, Clark R, Zvelebil M, Griffiths GM. Fas ligand is targeted to secretory lysosomes via a proline-rich domain in its cytoplasmic tail. J Cell Sci. 2001;114:2405\u201316.","journal-title":"J Cell Sci"},{"key":"8566_CR2","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1084\/jem.173.5.1099","volume":"173","author":"PJ Peters","year":"1991","unstructured":"Peters PJ, Borst J, Oorschot V, Fukuda M, Kr\u00e4henb\u00fchl O, Tschopp J, et al. Cytotoxic T lymphocyte granules are secretory lysosomes, containing both perforin and granzymes. J Exp Med. 1991;173:1099\u2013109.","journal-title":"J Exp Med"},{"key":"8566_CR3","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/nrm732","volume":"3","author":"EJ Blott","year":"2002","unstructured":"Blott EJ, Griffiths GM. Secretory lysosomes. Nat Rev Mol Cell Biol. 2002;3:122\u201331.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8566_CR4","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1002\/eji.1830190819","volume":"19","author":"PJ Peters","year":"1989","unstructured":"Peters PJ, Geuze HJ, Van der Donk HA, Slot JW, Griffith JM, Stam NJ, et al. Molecules relevant for T cell-target cell interaction are present in cytolytic granules of human T lymphocytes. Eur J Immunol. 1989;19:1469\u201375.","journal-title":"Eur J Immunol"},{"key":"8566_CR5","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.exer.2005.11.028","volume":"83","author":"NM McKechnie","year":"2006","unstructured":"McKechnie NM, King BC, Fletcher E, Braun G. Fas-ligand is stored in secretory lysosomes of ocular barrier epithelia and released with microvesicles. Exp Eye Res. 2006;83:304\u201314.","journal-title":"Exp Eye Res"},{"key":"8566_CR6","doi-asserted-by":"publisher","first-page":"G354","DOI":"10.1152\/ajpgi.2000.278.3.G354","volume":"278","author":"MJ Pinkoski","year":"2000","unstructured":"Pinkoski MJ, Brunner T, Green DR, Lin T. Fas and Fas ligand in gut and liver. Am J Physiol Gastrointest Liver Physiol. 2000;278:G354\u201366.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"8566_CR7","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.4049\/jimmunol.1300341","volume":"191","author":"L Bossaller","year":"2013","unstructured":"Bossaller L, Rathinam VA, Bonegio R, Chiang PI, Busto P, Wespiser AR, et al. Overexpression of membrane-bound fas ligand (CD95L) exacerbates autoimmune disease and renal pathology in pristane-induced lupus. J Immunol. 2013;191:2104\u201314.","journal-title":"J Immunol"},{"key":"8566_CR8","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/82712","volume":"1","author":"RM Siegel","year":"2000","unstructured":"Siegel RM, Chan FK, Chun HJ, Lenardo MJ. The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity. Nat Immunol. 2000;1:469\u201374.","journal-title":"Nat Immunol"},{"key":"8566_CR9","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1146\/annurev.iy.10.040192.001411","volume":"10","author":"JJ Cohen","year":"1992","unstructured":"Cohen JJ, Duke RC, Fadok VA, Sellins KS. Apoptosis and programmed cell death in immunity. Annu Rev Immunol. 1992;10:267\u201393.","journal-title":"Annu Rev Immunol"},{"key":"8566_CR10","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1046\/j.1440-1711.2002.01068.x","volume":"80","author":"S Maher","year":"2002","unstructured":"Maher S, Toomey D, Condron C, Bouchier-Hayes D. Activation-induced cell death: the controversial role of Fas and Fas ligand in immune privilege and tumour counterattack. Immunol cell Biol. 2002;80:131\u20137.","journal-title":"Immunol cell Biol"},{"key":"8566_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15502","volume":"8","author":"CY Lee","year":"2017","unstructured":"Lee CY, Lai TY, Tsai MK, Chang YC, Ho YH, Yu IS, et al. The ubiquitin ligase ZNRF1 promotes caveolin-1 ubiquitination and degradation to modulate inflammation. Nat Commun. 2017;8:15502.","journal-title":"Nat Commun"},{"key":"8566_CR12","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.bbrc.2009.09.011","volume":"389","author":"K Yoshida","year":"2009","unstructured":"Yoshida K, Watanabe M, Hatakeyama S. ZNRF1 interacts with tubulin and regulates cell morphogenesis. Biochem Biophys Res Commun. 2009;389:506\u201311.","journal-title":"Biochem Biophys Res Commun"},{"key":"8566_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.642625","volume":"9","author":"CH Shen","year":"2021","unstructured":"Shen CH, Chou CC, Lai TY, Hsu JE, Lin YS, Liu HY, et al. ZNRF1 Mediates Epidermal Growth Factor Receptor Ubiquitination to Control Receptor Lysosomal Trafficking and Degradation. Front Cell Dev Biol. 2021;9:642625.","journal-title":"Front Cell Dev Biol"},{"key":"8566_CR14","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1126\/science.7660125","volume":"269","author":"R K\u00fchn","year":"1995","unstructured":"K\u00fchn R, Schwenk F, Aguet M, Rajewsky K. Inducible gene targeting in mice. Science. 1995;269:1427\u20139.","journal-title":"Science"},{"key":"8566_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12865-014-0042-3","volume":"15","author":"HB Chu","year":"2014","unstructured":"Chu HB, Zhang TG, Zhao JH, Jian FG, Xu YB, Wang T, et al. Assessment of immune cells and function of the residual spleen after subtotal splenectomy due to splenomegaly in cirrhotic patients. BMC Immunol. 2014;15:42.","journal-title":"BMC Immunol"},{"key":"8566_CR16","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1146\/annurev-immunol-041015-055605","volume":"34","author":"CG Vinuesa","year":"2016","unstructured":"Vinuesa CG, Linterman MA, Yu D, MacLennan IC. Follicular helper T cells. Annu Rev Immunol. 2016;34:335\u201368.","journal-title":"Annu Rev Immunol"},{"key":"8566_CR17","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3389\/fimmu.2017.00306","volume":"8","author":"K de Leur","year":"2017","unstructured":"de Leur K, Dor FJ, Dieterich M, van der Laan LJ, Hendriks RW, Baan CC. IL-21 Receptor antagonist Inhibits differentiation of B cells toward plasmablasts upon alloantigen stimulation. Front Immunol. 2017;8:306.","journal-title":"Front Immunol"},{"key":"8566_CR18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/35040504","volume":"408","author":"J Parrish-Novak","year":"2000","unstructured":"Parrish-Novak J, Dillon SR, Nelson A, Hammond A, Sprecher C, Gross JA, et al. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature. 2000;408:57\u201363.","journal-title":"Nature"},{"key":"8566_CR19","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1126\/science.1077002","volume":"298","author":"K Ozaki","year":"2002","unstructured":"Ozaki K, Spolski R, Feng CG, Qi CF, Cheng J, Sher A, et al. A critical role for IL-21 in regulating immunoglobulin production. Sci (N Y, NY). 2002;298:1630\u20134.","journal-title":"Sci (N Y, NY)"},{"key":"8566_CR20","doi-asserted-by":"publisher","first-page":"5886","DOI":"10.4049\/jimmunol.179.9.5886","volume":"179","author":"S Kuchen","year":"2007","unstructured":"Kuchen S, Robbins R, Sims GP, Sheng C, Phillips TM, Lipsky PE, et al. Essential role of IL-21 in B cell activation, expansion, and plasma cell generation during CD4+ T cell-B cell collaboration. J Immunol. 2007;179:5886\u201396.","journal-title":"J Immunol"},{"key":"8566_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03750-7","volume":"9","author":"S Wang","year":"2018","unstructured":"Wang S, Wang J, Kumar V, Karnell JL, Naiman B, Gross PS, et al. IL-21 drives expansion and plasma cell differentiation of autoreactive CD11c(hi)T-bet(+) B cells in SLE. Nat Commun. 2018;9:1758.","journal-title":"Nat Commun"},{"key":"8566_CR22","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/0092-8674(94)90375-1","volume":"76","author":"T Takahashi","year":"1994","unstructured":"Takahashi T, Tanaka M, Brannan CI, Jenkins NA, Copeland NG, Suda T, et al. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell. 1994;76:969\u201376.","journal-title":"Cell"},{"key":"8566_CR23","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.4049\/jimmunol.172.4.2118","volume":"172","author":"S Karray","year":"2004","unstructured":"Karray S, Kress C, Cuvellier S, Hue-Beauvais C, Damotte D, Babinet C, et al. Complete loss of Fas ligand gene causes massive lymphoproliferation and early death, indicating a residual activity of gld allele. J Immunol. 2004;172:2118\u201325.","journal-title":"J Immunol"},{"key":"8566_CR24","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s00262-018-2269-y","volume":"68","author":"J Zhu","year":"2019","unstructured":"Zhu J, Petit PF, Van den Eynde BJ. Apoptosis of tumor-infiltrating T lymphocytes: a new immune checkpoint mechanism. Cancer Immunol Immunother. 2019;68:835\u201347.","journal-title":"Cancer Immunol Immunother"},{"key":"8566_CR25","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/4779","volume":"5","author":"G Bossi","year":"1999","unstructured":"Bossi G, Griffiths GM. Degranulation plays an essential part in regulating cell surface expression of Fas ligand in T cells and natural killer cells. Nat Med. 1999;5:90\u20136.","journal-title":"Nat Med"},{"key":"8566_CR26","doi-asserted-by":"publisher","first-page":"3943","DOI":"10.4049\/jimmunol.161.8.3943","volume":"161","author":"JH Li","year":"1998","unstructured":"Li JH, Rosen D, Ronen D, Behrens CK, Krammer PH, Clark WR, et al. The regulation of CD95 ligand expression and function in CTL. J Immunol. 1998;161:3943\u20139.","journal-title":"J Immunol"},{"key":"8566_CR27","doi-asserted-by":"publisher","first-page":"480","DOI":"10.4049\/jimmunol.162.1.480","volume":"162","author":"SB Brown","year":"1999","unstructured":"Brown SB, Savill J. Phagocytosis triggers macrophage release of Fas ligand and induces apoptosis of bystander leukocytes. J Immunol. 1999;162:480\u20135.","journal-title":"J Immunol"},{"key":"8566_CR28","doi-asserted-by":"publisher","first-page":"4292","DOI":"10.1158\/0008-5472.CAN-14-1848","volume":"75","author":"S Peyvandi","year":"2015","unstructured":"Peyvandi S, Buart S, Samah B, V\u00e9tizou M, Zhang Y, Durrieu L, et al. Fas ligand deficiency impairs tumor immunity by promoting an accumulation of monocytic myeloid-derived suppressor cells. Cancer Res. 2015;75:4292\u2013301.","journal-title":"Cancer Res"},{"key":"8566_CR29","doi-asserted-by":"publisher","first-page":"49772","DOI":"10.1109\/ACCESS.2023.3276232","volume":"11","author":"C Ritter","year":"2023","unstructured":"Ritter C, Thielemann R, Lee JY, Pham MT, Bartenschlager R, Rohr K. Multi-channel colocalization analysis and visualization of viral proteins in fluorescence microscopy images. IEEE Access. 2023;11:49772\u201384.","journal-title":"IEEE Access"},{"key":"8566_CR30","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4049\/jimmunol.1301277","volume":"192","author":"C Brochetta","year":"2014","unstructured":"Brochetta C, Suzuki R, Vita F, Soranzo MR, Claver J, Madjene LC, et al. Munc18-2 and syntaxin 3 control distinct essential steps in mast cell degranulation. J Immunol. 2014;192:41\u201351.","journal-title":"J Immunol"},{"key":"8566_CR31","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1242\/jcs.03315","volume":"120","author":"E Zuccato","year":"2007","unstructured":"Zuccato E, Blott EJ, Holt O, Sigismund S, Shaw M, Bossi G, et al. Sorting of Fas ligand to secretory lysosomes is regulated by mono-ubiquitylation and phosphorylation. J Cell Sci. 2007;120:191\u20139.","journal-title":"J Cell Sci"},{"key":"8566_CR32","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.1016\/j.molimm.2007.02.013","volume":"44","author":"S Tadokoro","year":"2007","unstructured":"Tadokoro S, Kurimoto T, Nakanishi M, Hirashima N. Munc18-2 regulates exocytotic membrane fusion positively interacting with syntaxin-3 in RBL-2H3 cells. Mol Immunol. 2007;44:3427\u201333.","journal-title":"Mol Immunol"},{"key":"8566_CR33","doi-asserted-by":"crossref","unstructured":"Lin YS, Chang YC, Chao TL, Tsai YM, Jhuang SJ, Ho YH, et al. The Src-ZNRF1 axis controls TLR3 trafficking and interferon responses to limit lung barrier damage. J Exp Med. 2023;220:e20220727.","DOI":"10.1084\/jem.20220727"},{"key":"8566_CR34","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0065-2776(08)60672-0","volume":"57","author":"S Nagata","year":"1994","unstructured":"Nagata S. Fas and Fas ligand: a death factor and its receptor. Adv Immunol. 1994;57:129\u201344.","journal-title":"Adv Immunol"},{"key":"8566_CR35","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1182\/blood-2008-09-179630","volume":"113","author":"A Magerus-Chatinet","year":"2009","unstructured":"Magerus-Chatinet A, Stolzenberg MC, Loffredo MS, Neven B, Schaffner C, Ducrot N, et al. FAS-L, IL-10, and double-negative CD4- CD8- TCR alpha\/beta+ T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of function. Blood. 2009;113:3027\u201330.","journal-title":"Blood"},{"key":"8566_CR36","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.1182\/blood.V97.10.3161","volume":"97","author":"U Lopatin","year":"2001","unstructured":"Lopatin U, Yao X, Williams RK, Bleesing JJ, Dale JK, Wong D, et al. Increases in circulating and lymphoid tissue interleukin-10 in autoimmune lymphoproliferative syndrome are associated with disease expression. Blood. 2001;97:3161\u201370.","journal-title":"Blood"},{"key":"8566_CR37","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1084\/jem.185.8.1511","volume":"185","author":"PA Kiener","year":"1997","unstructured":"Kiener PA, Davis PM, Starling GC, Mehlin C, Klebanoff SJ, Ledbetter JA, et al. Differential induction of apoptosis by Fas-Fas ligand interactions in human monocytes and macrophages. J Exp Med. 1997;185:1511\u20136.","journal-title":"J Exp Med"},{"key":"8566_CR38","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.4049\/jimmunol.159.4.1594","volume":"159","author":"PA Kiener","year":"1997","unstructured":"Kiener PA, Davis PM, Rankin BM, Klebanoff SJ, Ledbetter JA, Starling GC, et al. Human monocytic cells contain high levels of intracellular Fas ligand: rapid release following cellular activation. J Immunol. 1997;159:1594\u20138.","journal-title":"J Immunol"},{"key":"8566_CR39","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0021-9150(01)00631-1","volume":"161","author":"T Imanishi","year":"2002","unstructured":"Imanishi T, Han DK, Hofstra L, Hano T, Nishio I, Liles WC, et al. Apoptosis of vascular smooth muscle cells is induced by Fas ligand derived from monocytes\/macrophage. Atherosclerosis. 2002;161:143\u201351.","journal-title":"Atherosclerosis"},{"key":"8566_CR40","doi-asserted-by":"publisher","first-page":"a016840","DOI":"10.1101\/cshperspect.a016840","volume":"6","author":"JP Luzio","year":"2014","unstructured":"Luzio JP, Hackmann Y, Dieckmann NM, Griffiths GM. The biogenesis of lysosomes and lysosome-related organelles. Cold Spring Harb Perspect Biol. 2014;6:a016840.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"8566_CR41","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.imlet.2006.10.001","volume":"108","author":"M Lettau","year":"2007","unstructured":"Lettau M, Schmidt H, Kabelitz D, Janssen O. Secretory lysosomes and their cargo in T and NK cells. Immunol Lett. 2007;108:10\u20139.","journal-title":"Immunol Lett"},{"key":"8566_CR42","doi-asserted-by":"publisher","first-page":"3765","DOI":"10.1172\/JCI40732","volume":"119","author":"M C\u00f4te","year":"2009","unstructured":"C\u00f4te M, M\u00e9nager MM, Burgess A, Mahlaoui N, Picard C, Schaffner C, et al. Munc18-2 deficiency causes familial hemophagocytic lymphohistiocytosis type 5 and impairs cytotoxic granule exocytosis in patient NK cells. J Clin Investig. 2009;119:3765\u201373.","journal-title":"J Clin Investig"},{"key":"8566_CR43","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.ajhg.2009.09.005","volume":"85","author":"U zur Stadt","year":"2009","unstructured":"zur Stadt U, Rohr J, Seifert W, Koch F, Grieve S, Pagel J, et al. Familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) is caused by mutations in Munc18-2 and impaired binding to syntaxin 11. Am J Hum Genet. 2009;85:482\u201392.","journal-title":"Am J Hum Genet"},{"key":"8566_CR44","doi-asserted-by":"publisher","first-page":"4784","DOI":"10.1074\/jbc.RA118.006922","volume":"294","author":"EI Cardenas","year":"2019","unstructured":"Cardenas EI, Gonzalez R, Breaux K, Da Q, Gutierrez BA, Ramos MA, et al. Munc18-2, but not Munc18-1 or Munc18-3, regulates platelet exocytosis, hemostasis, and thrombosis. J Biol Chem. 2019;294:4784\u201392.","journal-title":"J Biol Chem"},{"key":"8566_CR45","doi-asserted-by":"publisher","first-page":"6016","DOI":"10.1182\/blood-2011-12-398958","volume":"119","author":"J Pagel","year":"2012","unstructured":"Pagel J, Beutel K, Lehmberg K, Koch F, Maul-Pavicic A, Rohlfs AK, et al. Distinct mutations in STXBP2 are associated with variable clinical presentations in patients with familial hemophagocytic lymphohistiocytosis type 5 (FHL5). Blood. 2012;119:6016\u201324.","journal-title":"Blood"},{"key":"8566_CR46","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1083\/jcb.96.3.887","volume":"96","author":"IS Mellman","year":"1983","unstructured":"Mellman IS, Plutner H, Steinman RM, Unkeless JC, Cohn ZA. Internalization and degradation of macrophage Fc receptors during receptor-mediated phagocytosis. J Cell Biol. 1983;96:887\u201395.","journal-title":"J Cell Biol"},{"key":"8566_CR47","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1096\/fj.08-109439","volume":"23","author":"A Bunbury","year":"2009","unstructured":"Bunbury A, Potolicchio I, Maitra R, Santambrogio L. Functional analysis of monocyte MHC class II compartments. FASEB J. 2009;23:164\u201371.","journal-title":"FASEB J"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08566-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08566-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08566-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T13:02:44Z","timestamp":1778158964000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08566-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,28]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8566"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08566-8","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,28]]},"assertion":[{"value":"26 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All animal experiments were performed in accordance with the relevant guidelines and regulations and were approved by the Institutional Animal Care and Use Committee (IACUC) of the National Taiwan University College of Medicine Laboratory Animal Center, Taipei, Taiwan (Approval No. 20201165).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"422"}}